Interim Management Statement

Keystone Investment Trust plc Interim Management Statement for the three months ended 31 December 2012 Material Events The Company issued 75,000 ordinary shares in October 2012 at an average price of 1341.7p. No other material events occurred in the period. Dividends In the period an interim dividend of 30.5p per ordinary share was paid on 14 December 2012 to shareholders on the register on 23 November 2012. The shares were marked ex-dividend on 21 November 2012. Performance - Total Return 3 Months 1 Year 3 Years 5 Years Share Price 3.7% 21.0% 51.9% 42.3% Net Asset Value 4.0% 12.9% 35.2% 27.2% FTSE All-Share Index 3.8% 12.3% 24.2% 13.2% Source: Thomson Reuters Datastream Share Price and Discount For the Three Months Ended 31 Dec 2012 As at 31 Dec 2012 High Low Average Share Price (pence) 1335.00 1355.00 1283.00 1321.36 Discount (debt at par) 2.3% Premium (debt at fair 2.0% value) Source: Thomson Reuters Datastream Assets and Gearing 31 Dec 2012 Total Gross Assets (£m) 215.5 of which cash and cash equivalents (£m) 12.8 Borrowings (£m) 31.9 Cum Income Net Asset Value (pence) 1366.0 Gross Gearing 17.4% Net Gearing 10.2% `Gross Gearing' reflects the amount of gross borrowings in use by a company and takes no accounts of any cash balances. It is based on gross borrowings as a percentage of shareholders' funds. `Net Gearing' reflects the amount of net borrowings invested, i.e borrowings less cash and bond holdings. It is based on net borrowings as a percentage of shareholders' funds. Sector Breakdown of Portfolio (excluding Cash and Certificates of Deposit) 31 Dec 2012 Healthcare 20.6% Consumer Goods 19.3% Financials 18.5% Industrials 13.7% Consumer Services 11.6% Telecommunications 10.4% Utilities 5.5% Basic Materials 0.2% Fixed Interest 0.2% 100.0% Top Ten Holdings Investments % of Portfolio Imperial Tobacco 5.7% BT 5.4% British American Tobacco 4.9% Reynolds American 4.6% - US Common Stock AstraZeneca 4.4% Roche - Swiss Common Stock 4.2% Novartis - Swiss Common Stock 3.7% GlaxoSmithKline 3.7% BAE Systems 3.4% Reckitt Benckiser 3.4% All ordinary shares unless otherwise stated Changes to Share Capital Ordinary Shares of 50p each Issued As at 30 Sep 2012 13,368,799 Shares bought back 0 Shares issued 75,000 As at 31 Dec 2012 13,433,799 The Company has authority to buy back shares for cancellation and to issue new shares (disapplying pre-emption rights), in each case within specified limits. The Company expects to renew these authorities each year. Price and Performance The Company's Ordinary shares are listed on the London Stock Exchange and the price is published in the Times and the Financial Times under `Investment Companies' and in the Daily Telegraph under `Investment Trusts'. The Company's net asset value is calculated on a daily basis and can be viewed on the London Stock Exchange website at www.londonstockexchange.com Further information can be obtained from Invesco Perpetual as follows: Free Investor Helpline: 0800 085 8677 Internet address: www.invescoperpetual.co.uk/investmenttrusts The information provided in this statement should not be considered as a financial promotion. For and on behalf of Invesco Asset Management Limited 22 January 2013
UK 100

Latest directors dealings